Filtered By:
Source: Expert Review of Neurotherapeutics
Drug: Wellbutrin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 430 results found since Jan 2013.
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence
Expert Rev Neurother. 2023 Mar 21:1-8. doi: 10.1080/14737175.2023.2192402. Online ahead of print.ABSTRACTINTRODUCTION: Major depressive disorder (MDD) is one of the leading causes of disability worldwide. However, many patients do not achieve an adequate clinical improvement with pharmacotherapies targeting monoamine receptors, and the onset of therapeutic benefit typically lags by 4-6 weeks. There is a significant need for mechanistically novel treatments with more rapid efficacy. Combinations of dextromethorphan, an oral N-methyl-D-aspartate (NMDA) receptor antagonist, can potentially fill this gap.AREAS COVERED: US Clin...
Source: Expert Review of Neurotherapeutics - March 21, 2023 Category: Neurology Authors: Zamfira Parincu Dan V Iosifescu Source Type: research
